Piperacillin and Tazobactam Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Piperacillin and Tazobactam Injection (injection) from Fresenius Kabi USA, LLC with status To Be Discontinued. The shortage was first posted on 01/20/2026.
Shortage Details
- Status
- To Be Discontinued
- Company
- Fresenius Kabi USA, LLC
- Package NDC
- 65219-434-20
- Dosage Form
- Injection
- Presentation
- Piperacillin and Tazobactam, Injection, 2.25 g vial (NDC 65219-434-20)
- Initial Posting
- 01/20/2026
- Revised Date